blfs: the income statement

MyFinsight

BIOLIFE SOLUTIONS INC (BLFS)

For the quarter ending 2025-06-30, BLFS made $25,421K in revenue. -$15,838K in net income. Net profit margin of -62.30%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Total product, rental, and service revenue	25,421	23,941	30,571	28,328
Cost of goods and services sold (exclusive of intangible assets amortization)	-	8,155	14,276	11,941
Sales and marketing	2,732	2,597	3,543	3,502
Research and development	2,719	2,204	2,050	2,382
General and administrative	11,396	11,501	11,351	10,894
Cost of goods and services sold (exclusive of intangible assets amortization)-Service	9	-	-	-
Cost of goods and services sold (exclusive of intangible assets amortization)-Product	8,035	-	-	-
Cost of goods and services sold (exclusive of intangible assets amortization)-Rental Revenue	944	-	-	-
Intangible asset amortization	708	702	910	910
Ipr&d expense	15,521	-	-	-
Total operating expenses	42,064	25,159	32,130	31,123
Operating loss	-16,643	-1,218	-1,559	-2,795
Other income	247	103	95	84
Interest income (expense), net	684	681	-267	-361
Change in fair value of equity investments	-	-	-	-4,074
Total other income (expense), net	931	784	-172	-4,351
Loss before income tax expense	-15,712	-434	-1,731	-7,146
Income tax expense	126	14	-28	-
Net loss from continuing operations	-15,838	-448	-1,703	-7,146
Income tax expense	-	-	-	-
Loss from discontinued operations before income tax expense	-	-	-	-13,573
Loss from discontinued operations	-	-	-	-13,573
Net loss	-15,838	-448	-1,703	-20,719
Basic	-15,838	-448	-1,703	-20,719
Diluted	-	-	-1,703	-

Basic (in dollars per share)	-0.33	-0.01	-0.04	-0.45
Basic (in shares)	47,798,146	47,134,720	46,175,345	46,004,037
Diluted (in dollars per share)	-0.33	-0.01	-0.04	-0.45
Diluted (in shares)	47,798,146	47,134,720	46,175,345	46,004,037

Unit: Thousand (K) dollars (except for numbers of shares and EPS)